De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome

American Journal of Human Genetics
Tsutomu TokiEtsuro Ito

Abstract

Inherited bone-marrow-failure syndromes (IBMFSs) include heterogeneous genetic disorders characterized by bone-marrow failure, congenital anomalies, and an increased risk of malignancy. Many lines of evidence have suggested that p53 activation might be central to the pathogenesis of IBMFSs, including Diamond-Blackfan anemia (DBA) and dyskeratosis congenita (DC). However, the exact role of p53 activation in each clinical feature remains unknown. Here, we report unique de novo TP53 germline variants found in two individuals with an IBMFS accompanied by hypogammaglobulinemia, growth retardation, and microcephaly mimicking DBA and DC. TP53 is a tumor-suppressor gene most frequently mutated in human cancers, and occasional germline variants occur in Li-Fraumeni cancer-predisposition syndrome. Most of these mutations affect the core DNA-binding domain, leading to compromised transcriptional activities. In contrast, the variants found in the two individuals studied here caused the same truncation of the protein, resulting in the loss of 32 residues from the C-terminal domain (CTD). Unexpectedly, the p53 mutant had augmented transcriptional activities, an observation not previously described in humans. When we expressed this mutant in ...Continue Reading

References

Nov 17, 2006·Nature·Jing HuangShelley L Berger
Aug 2, 2008·British Journal of Haematology·Adrianna VlachosUNKNOWN Participants of Sixth Annual Daniella Maria Arturi International Consensus Conference
Dec 17, 2009·The New England Journal of Medicine·Rodrigo T Calado, Neal S Young
Mar 3, 2010·Blood·Anupama Narla, Benjamin L Ebert
Nov 11, 2010·Clinical and Experimental Immunology·S KhanA Huissoon
Feb 3, 2011·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·S JyonouchiK E Sullivan
Jun 19, 2012·The Journal of Clinical Investigation·Vijay G SankaranHanna T Gazda
Feb 26, 2013·American Journal of Human Genetics·Shinji KunishimaSeishi Ogawa
Jun 19, 2013·Cell Reports·Iva SimeonovaFranck Toledo
Sep 23, 2014·Blood·Danielle M TownsleyNeal S Young
Jan 17, 2016·Nucleic Acids Research·Nele HugJavier F Cáceres
May 28, 2016·Science·David MalkinStephen H Friend

❮ Previous
Next ❯

Citations

Jan 10, 2019·Journal of Molecular Cell Biology·Margot E Bowen, Laura D Attardi
Jul 24, 2020·Blood·Lydie Da CostaNarla Mohandas
Oct 23, 2020·Science Translational Medicine·Alison M TaylorLeonard I Zon
May 6, 2021·Cell Reports Medicine·Rossana ApriglianoBarbara van Loon
Oct 27, 2021·Annual Review of Pathology·Mengxiong Wang, Laura D Attardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.